References
- Rattman W, Ziegler D, Jahnke M, Haastert B, Gries F A. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med 1993; 10: 664–671, [CSA]
- Ewing D Jm, Clarke B F. Diabetic autonomic neuropathy: present insights and further prospects. Diabetes Care 1986; 9: 648, [PUBMED], [INFOTRIEVE]
- Pomeranz B, Maaulay R J.B, Caudil M A. Assessment of autonomic function in human by heart rate spectral analysis. Am J Physiol 1985; 248: H151–H153, [PUBMED], [INFOTRIEVE]
- Bellavere F, Ferri M, Guaini L. Prolonged QT period in diabetic autonomic neuropathy. Br Heart J 1988; 59: 379–383, [PUBMED], [INFOTRIEVE]
- Shimabukuro M, Chibana T, Yoshida H, Namamine F, Komiya I, Takasu N. Increased QT dispersion and cardiac adrenergic dysinnervaton in diatetic patients with autonomic patients. Am J Cardiol 1996; 78: 1057–1059, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sawicki R T, Dahne R, Berger B M. Prolonged QT interval as a predictor of mortality in diabetic neuropathy. Diabetologia 1996; 39: 77–81, [PUBMED], [INFOTRIEVE], [CSA]
- Donaghue K C, Bonney M, Simpson J M. Autonomic and peripheral nerve function in adolescents with and without diabetes. Diabet Med 1993; 10: 664–671, [PUBMED], [INFOTRIEVE], [CSA]
- Noritake M, Takase B, Kudoh K. Diurnal change in heart rate variability in healthy and diabetic subjects. Intern Med 1992; 31: 453–456, [PUBMED], [INFOTRIEVE]
- Morrish N J, Stevens L K, Head J, Fuller J H, Jarrett R J, Keen H. A prospective study of mortality among middle‐aged diabetic patients. Diabetologia 1990; 33: 538–541, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Abe H, Sumiyoshi M, Kohshi K, Nakashima Y. Effects of orthostatic self‐training on head‐up tilt testing for the prevention of tilt‐induced neurocardiogenic syncope. Comparison of pharmacological therapy. Clin Exp Hypertens 2003; 25: 191–198, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Grubb B P, Kosinski D. Tilt table testing concepts and limitations. PACE 1997; 20: 781–787, [PUBMED], [INFOTRIEVE]
- Grubb B P, Abe H. Syndromes of autonomic dysfunction associated with orthostatic intolerance: a brief review of pathophysiology, diagnosis and management. J Arrhythm 1999; 15: 276–284
- Hilsted J. Pathopysiology in diabetic autonomic neuropathy. Cardiovascular, humoral, and metabolic studies. N Y State J Med 1982; 82: 892–903, [PUBMED], [INFOTRIEVE]
- Kuo C S, Munakata K, Reddy C P, Surawicz B. Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation 1983; 67: 1356–1367, [PUBMED], [INFOTRIEVE]
- Day C P, McComb J M, Campbell R W. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 1990; 63: 342–344, [PUBMED], [INFOTRIEVE]
- Barr C S, Naas A, Freeman M, Lang C C, Struthers A D. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994; 343: 327–329, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ewing D J, Boland O, Neilsen J M.M, Cho C G, Clarke B F. Autonomic neuropathy, QT interval lengthening and unexpected deaths in male diabetic patients. Diabetologia 1991; 34: 182–185, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ong J J.C, Sarma J S.M, Venkataraman K, Levin S R, Singh B N. Circadian rhthmicity heart rate and QTc interval in diabetic autonomic neuropathy: implications for the mechanism of sudden death. Am Heart J 1993; 125: 744–752, [PUBMED], [INFOTRIEVE], [CROSSREF]